@misc{indiciae93cf4b26d200,
  title = {Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2},
  author = {Bakovic, A. and Risner, K. and Bhalla, N. and Alem, F. and Chang, T. L. and Weston, W. and Harness, J. A. and Narayanan, A.},
  year = {2020},
  doi = {10.1101/2020.10.29.352450},
  url = {https://www.biorxiv.org/content/10.1101/2020.10.29.352450v1},
  note = {Source identifier: 10.1101/2020.10.29.352450}
}